Home Carboxys 1-Phenanthrenecarboxylic acid,1,2,3,4,4a,9,10,10a-octahydro-6-hydroxy-1,4a-dimethyl-,(1S,4aS,10aR)-

1-Phenanthrenecarboxylic acid,1,2,3,4,4a,9,10,10a-octahydro-6-hydroxy-1,4a-dimethyl-,(1S,4aS,10aR)-

CAS No.:
5947-49-9
Catalog Number:
AG00IAK2
Molecular Formula:
C17H22O3
Molecular Weight:
274.3548
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
10mg
99%
1 week
United States
$140
- +
50mg
99%
1 week
United States
$357
- +
Product Description
Catalog Number:
AG00IAK2
Chemical Name:
1-Phenanthrenecarboxylic acid,1,2,3,4,4a,9,10,10a-octahydro-6-hydroxy-1,4a-dimethyl-,(1S,4aS,10aR)-
CAS Number:
5947-49-9
Molecular Formula:
C17H22O3
Molecular Weight:
274.3548
MDL Number:
MFCD00074825
IUPAC Name:
(1S,4aS,10aR)-6-hydroxy-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid
InChI:
InChI=1S/C17H22O3/c1-16-8-3-9-17(2,15(19)20)14(16)7-5-11-4-6-12(18)10-13(11)16/h4,6,10,14,18H,3,5,7-9H2,1-2H3,(H,19,20)/t14-,16-,17+/m1/s1
InChI Key:
VJILEYKNALCDDV-OIISXLGYSA-N
SMILES:
Oc1ccc2c(c1)[C@@]1(C)CCC[C@]([C@@H]1CC2)(C)C(=O)O
EC Number:
227-706-3
UNII:
7K80G5Z96Y
Properties
Complexity:
407  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Defined Bond Stereocenter Count:
0
Exact Mass:
274.157g/mol
Formal Charge:
0
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
274.36g/mol
Monoisotopic Mass:
274.157g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
57.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.1  
Literature
Title Journal
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry 20121115
Identification of novel liver X receptor activators by structure-based modeling. Journal of chemical information and modeling 20120525
Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro. Evidence-based complementary and alternative medicine : eCAM 20110101
Design, synthesis, and characterization of BK channel openers based on oximation of abietane diterpene derivatives. Bioorganic & medicinal chemistry 20101215
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Microbial transformation of podocarpic acid and evaluation of transformation products for antioxidant activity. Planta medica 20100501
In silico identification of anthropogenic chemicals as ligands of zebrafish sex hormone binding globulin. Toxicology and applied pharmacology 20090101
Cancer chemopreventive activity of 'rosin' constituents of Pinus spez. and their derivatives in two-stage mouse skin carcinogenesis test. Phytomedicine : international journal of phytotherapy and phytopharmacology 20081101
Design, synthesis and characterization of podocarpate derivatives as openers of BK channels. Bioorganic & medicinal chemistry letters 20081001
Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists. Current medicinal chemistry 20080101
Design, synthesis, and structure-activity relationship of podocarpic acid amides as liver X receptor agonists for potential treatment of atherosclerosis. Bioorganic & medicinal chemistry letters 20051015
Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources. Journal of natural products 20050801
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters. Bioorganic & medicinal chemistry letters 20050602
Dimethyl 6-methoxy-4abeta-methyl-9-oxo-1,2,3,4,4a,9,10,10abeta-octahydrophenanthrene-1,1-dicarboxylate. Acta crystallographica. Section C, Crystal structure communications 20030301
Properties